BWM
RMD icon

Brophy Wealth Management’s ResMed RMD Stock Holding History

Brophy Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$352K Buy
+1,440
New +$322K 0.13% 162

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Brophy Wealth Management's RMD Position: Q3 2024 in Review

Brophy Wealth Management opened a new position in ResMed (RMD) in Q3 2024: 1,440 shares worth $352K. The stake represents 0.13% of the portfolio and ranks #162 among its holdings.

801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • Brophy Wealth Management held 1,440 shares of ResMed worth $352K as of Q3 2024.
  • ResMed was a new Brophy Wealth Management position in Q3 2024.
  • ResMed made up 0.13% of Brophy Wealth Management's portfolio in Q3 2024, its #162 holding.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on Brophy Wealth Management's 13F filing for Q3 2024, filed 15 Nov 2024.